Keyphrases
Antibody Fragment
33%
Anticancer Therapeutics
33%
Antigen-binding Site
100%
Cancer Cell Lines
100%
Caspase-independent
33%
Cell Death
66%
Cross-linker
66%
Cytotoxic Activity
33%
Fully Human
100%
HL-60 Cells
33%
Induced Cell Death
33%
Jurkat
33%
Leukemia Cell Lines
33%
Monoclonal Antibody
33%
Monovalent Cations
100%
Phage Display Technology
33%
Receptor 2
33%
TRAIL Receptors
100%
Tumor Cell Death
33%
Tumor Cells
33%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
33%
Pharmacology, Toxicology and Pharmaceutical Science
Caspase
50%
Cytokine
50%
Death Receptor 5
50%
Human Monoclonal Antibody
50%
Leukemia
50%
Malignant Neoplasm
100%
Neoplasm
100%
Recombinant
50%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
50%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
100%
Biochemistry, Genetics and Molecular Biology
Anticancer
16%
Cancer Cell
100%
Caspase
16%
Cell Death
66%
Cytokine
16%
Cytotoxicity
16%
Fragment Antigen-Binding
100%
Monoclonal Antibody
16%
Phage Display
16%
Programmed Cell Death
16%
Recombinant
16%
TRAIL
100%
Tumor Necrosis Factor
16%
Immunology and Microbiology
Cancer Cell Line
100%
Caspase
16%
Cell Death
66%
Cytokine
16%
Cytotoxicity
16%
Fragment Antigen-Binding
100%
Human Monoclonal Antibody
16%
Leukemia Cell Line
16%
Phage Display
16%
TNF related apoptosis inducing ligand
100%
Tumor Cell
33%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
16%
Medicine and Dentistry
Phage Display
25%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
50%